Cargando…
PEA‐15 (Phosphoprotein Enriched in Astrocytes 15) Is a Protective Mediator in the Vasculature and Is Regulated During Neointimal Hyperplasia
BACKGROUND: Neointimal hyperplasia following angioplasty occurs via vascular smooth muscle cell proliferation. The mechanisms involved are not fully understood but include mitogen‐activated protein kinases ERK1/2 (extracellular signal–regulated kinases 1 and 2). We recently identified the intracellu...
Autores principales: | Greig, Fiona H., Kennedy, Simon, Gibson, George, Ramos, Joe W., Nixon, Graeme F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634313/ https://www.ncbi.nlm.nih.gov/pubmed/28893763 http://dx.doi.org/10.1161/JAHA.117.006936 |
Ejemplares similares
-
Phosphoprotein enriched in astrocytes (PEA)-15: A potential therapeutic target in multiple disease states
por: Greig, Fiona H., et al.
Publicado: (2014) -
Phosphoprotein enriched in astrocytes (PEA)-15 is a novel regulator of adipose tissue expansion
por: Verschoor, Pola J., et al.
Publicado: (2021) -
Vitamin D(3) signalling in the brain enhances the function of phosphoprotein enriched in astrocytes – 15 kD (PEA-15)
por: Obradovic, Darja, et al.
Publicado: (2009) -
Phosphoprotein Enriched in Astrocytes 15 kDa (PEA-15) Reprograms Growth Factor Signaling by Inhibiting Threonine Phosphorylation of Fibroblast Receptor Substrate 2α
por: Haling, Jacob R., et al.
Publicado: (2010) -
Phosphoprotein enriched in diabetes (PED/PEA15) promotes migration in hepatocellular carcinoma and confers resistance to sorafenib
por: Quintavalle, Cristina, et al.
Publicado: (2017)